triple-negative breast cancer

Open Access
Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer
Yaxin Zhao, Han Wang, Ying Wang, Yizhou Jiang, Xin Hu and Zhiming Shao

Cancer Biology & Medicine March 2026, 23 (3) 374-391; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0691
Open Access
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
Yuling Xiao, Hang Zhang, Yi Xiao, Ying Wang, Jing Zhang, Qi Hua, Pengchen Hu, Xinyan Lyu, Weihua Shou, Xin Hu, Zhiming Shao, Yizhou Jiang, Wei Huang and Jinxiu Shi

Cancer Biology & Medicine July 2025, 22 (7) 854-870; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0038
Open Access
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer
Xiuzhi Zhu, Xiaohan Ying, Yin Liu, Yunyi Wang, Li Chen, Zhiming Shao, Xi Jin, Yizhou Jiang and Zhonghua Wang

Cancer Biology & Medicine September 2024, 21 (9) 784-798; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0009
You have access
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
Yimeng Chen, Xue Wang, Feng Du, Jian Yue, Yiran Si, Xiaochen Zhao, Lina Cui, Bei Zhang, Ting Bei, Binghe Xu and Peng Yuan

Cancer Biology & Medicine February 2023, 20 (2) 155-168; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0525
You have access
The advance of adjuvant treatment for triple-negative breast cancer
Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu

Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
You have access
The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency
Yayun Gu, Cheng Wang, Rongxuan Zhu, Jianshui Yang, Wenwen Yuan, Yanhui Zhu, Yan Zhou, Na Qin, Hongbing Shen, Hongxia Ma, Hongxia Wang, Xiaoan Liu and Zhibin Hu

Cancer Biology & Medicine February 2021, 18 (1) 74-87; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0071
You have access
Metabolic reprogramming in triple-negative breast cancer
Zhanyu Wang, Qianjin Jiang and Chenfang Dong

Cancer Biology & Medicine February 2020, 17 (1) 44-59; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0210
You have access
Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer
Huizhi Sun, Nan Yao, Siqi Cheng, Linqi Li, Shiqi Liu, Zhao Yang, Guanjie Shang, Danfang Zhang and Zhi Yao

Cancer Biology & Medicine May 2019, 16 (2) 299-311; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0209
You have access
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients
Yuhan Zhang, Shuaibing Wang, Beibei Yang, Su Lu, Yiyi Du and Hong Liu

Cancer Biology & Medicine May 2019, 16 (2) 350-360; DOI: https://doi.org/10.20892/j.issn.2095-3941.2018.0378

Main menu

User menu

Search

triple-negative breast cancer

Navigate

More Information

For Authors

Journal Services